Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1990-02-27
1991-10-01
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
A61K 3159
Patent
active
050534017
ABSTRACT:
An osteogenesis promotion with use of a vitamin D derivative of the formula: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3, which may be the same or different, each represents a hydrogen atom or a hydroxyl group; and R.sub.4 is a hydrogen atom or a lower alkyl group having 4-6 carbon atoms that may or may not be substituted by a hydroxyl group, are disclosed. A pharmaceutical composition comprising the above derivatives is useful as a therapeutic agent for osteoporosis.
REFERENCES:
patent: 4891364 (1990-01-01), Kubodera et al.
Holick et al., C.A. 82:110660r (1975).
Kubodera et al., C.A. 106:84945e (1987).
Abe et al., C.A. 108:88191v (1988).
Abe et al., C.A. 110:69959b (1989).
Valaja et al., C.A. 113:109898b (1990).
Matsumoto Toshio
Nishii Yasuho
Chugai Seiyaku Kabushiki Kaisha
Rose Shep K.
LandOfFree
Osteogenesis promotion with use of vitamin D derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteogenesis promotion with use of vitamin D derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteogenesis promotion with use of vitamin D derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755114